The Effect of Active Exercise on Maintenance Haemodialysis Patients
Launched by YUNFENG XIA · Aug 21, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how physical exercise affects patients who are on maintenance haemodialysis, which is a treatment for kidney failure. The main goal is to find out if regular exercise can improve things like nutrition, reduce inflammation, build muscle strength, and lower the risk of heart and brain-related health issues. Researchers will compare a group of patients who do exercise with another group that receives standard treatment to see what differences occur.
To participate, you should have been on maintenance haemodialysis for at least three months and be in stable health, without serious infections or heart problems. If you join, you will be asked to engage in low-intensity exercises, such as walking, swimming, or Tai Chi, for at least 30 minutes, three times a week. You’ll choose activities that suit your abilities and are encouraged to keep track of your exercise intensity. This study aims to help improve the overall health and wellbeing of patients on dialysis, so if you think you might be eligible and are willing to take part, it could be a great opportunity to contribute to important research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • MHD more than 3 months, 3 times per week, 3-4h each time;
- • Urea clearance index (Kt/V) \>1.2;
- • Stable condition, no serious infection, tumour and cardiovascular disease;
- • Willing to join the study and sign the informed consent form.
- Exclusion Criteria:
- • Combined with serious heart and lung disease: such as repeated heart failure, severe arrhythmia, unstable angina pectoris, severe pericardial effusion, severe heart valve disease, hypertrophic cardiomyopathy, aortic coarctation, severe emphysema, pulmonary heart disease, severe pulmonary hypertension (average pressure of the pulmonary artery \> 55mmHg), etc.;
- • Combined with chronic joints, muscles, or vascular disease can not be or is not suitable for regular exercise, such as cerebrovascular disease; combined chronic joint, muscle or vascular disease can not or are not suitable for regular exercise, such as cerebrovascular disease sequelae, serious lower limb joint damage, severe myopathy, deep vein thrombosis, etc.;
- • unwilling to cooperate with the movement of people
About Yunfeng Xia
Yunfeng Xia is a dedicated clinical trial sponsor specializing in innovative therapeutic solutions aimed at addressing unmet medical needs. With a strong emphasis on rigorous research methodologies and ethical standards, Yunfeng Xia collaborates with leading researchers and healthcare institutions to design and execute clinical trials that advance medical knowledge and improve patient outcomes. Committed to transparency and regulatory compliance, the organization leverages state-of-the-art technology and data analytics to facilitate efficient trial management and ensure the highest quality of clinical evidence. Through its initiatives, Yunfeng Xia aims to contribute significantly to the development of safe and effective treatments across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, Chongqing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported